Meeder Asset Management Inc Takeda Pharmaceutical CO LTD Transaction History

Meeder Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$13.17 - $16.4 $895 - $1,115	-68 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$16.3 - $17.26 $1,010 - $1,070	62 Added 1033.33%	68 $1,000
Q2 2021 Aug 09, 2021	SELL	$16.55 - $18.64 $15,226 - $17,148	-920 Reduced 99.35%	6 $0
Q1 2021 Apr 28, 2021	BUY	$16.71 - $19.9 $15,055 - $17,929	901 Added 3604.0%	926 $17,000
Q4 2020 Feb 09, 2021	SELL	$15.39 - $18.97 $61 - $75	-4 Reduced 13.79%	25 $0
Q3 2020 Nov 02, 2020	BUY	$17.1 - $19.19 $495 - $556	29 New	29 $1,000
Q2 2020 Aug 11, 2020	SELL	$14.59 - $19.5 $2,786 - $3,724	-191 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$16.58 - $20.49 $3,166 - $3,913	191 New	191 $3,000

319

70.3M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.9B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.